BRCC3 anticorps (AA 266-316)

N° du produit ABIN1977072

Cet anticorps anti-BRCC3 est un anticorps Lapin Polyclonal détectant BRCC3 dans WB, IHC, IP, IHC (p) et IF. Adapté pour Humain, Souris, Cheval et Porc.

Aperçu rapide pour BRCC3 anticorps (AA 266-316) (ABIN1977072)

Antigène: BRCC3 (BRCA1/BRCA2-Containing Complex, Subunit 3 (BRCC3))

Reactivité: Humain, Souris, Cheval, Porc

Hôte: Lapin

Clonalité: Polyclonal

Conjugué: Cet anticorp BRCC3 est non-conjugé

Application: Western Blotting (WB), Immunohistochemistry (IHC), Immunoprecipitation (IP), Immunohistochemistry (Paraffin-embedded Sections) (IHC (p)), Immunofluorescence (IF)

Détail du produit anti-BRCC3 anticorps

Épitope: AA 266-316

Specificité: Region between residue 266 and 316 of human BRCA1/BRCA2-containing complex subunit 36 using the numbering given in entry NP_077308.1 (GeneID 79184).

Purification: Immunoaffinity purified

Isotype: IgG

Information d'application

Indications d'application: Approved: IF (1:250 - 1:2000), IHC, IHC-P (1:500 - 1:2000), IP (2 - 5 μg/mg lysate), WB (1:2000 - 1:10000)

Usage: Immunohistochemistry: Antigen retrieval with citrate buffer  pH 6.0 is recommended for FFPE tissue sections. Human controls: Breast Carcinoma, Ovarian Carcinoma, Prostate Carcinoma.

Commentaires:

Target Species of Antibody: Human

Restrictions: For Research Use only

Stockage

Format: Liquid

Concentration: Lot specific

Buffer: Tris-citrate/phosphate buffer,  pH 7-8, 0.09 % sodium azide.

Agent conservateur: Sodium azide

Précaution d'utilisation: This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.

Stock: 4 °C

Stockage commentaire: Store at 2-8°C for up to 1 year.

Date de péremption: 12 months

Détails sur BRCC3

Antigène: BRCC3 (BRCA1/BRCA2-Containing Complex, Subunit 3 (BRCC3))

Autre désignation: BRCC3 / BRCC36

Sujet: Name/Gene ID: BRCC3

Synonyms: BRCC3, C6.1A, BRCC36, BRISC complex subunit BRCC36, BRCA1-A complex subunit BRCC36, CXorf53, RP11-143H17.2

ID gène: 79184

Pathways: Positive Regulation of Response to DNA Damage Stimulus